Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Ionis Pharmaceuticals, Inc. (IONS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Ionis Pharmaceuticals, Inc. (IONS), most recent 12 months reported: revenue $874.09M, net loss $565.17M, free cash flow -$560.84M. Latest balance sheet on file: liquid cash $2.05B, total debt $1.32B, net cash $731.97M. From SEC filings. Others in Pharmaceutical Preparations: PRESTIGE CONSUMER HEALTHCARE INC. · PTC Therapeutics, Inc. · ANI PHARMACEUTICALS, INC · HARMONY BIOSCIENCES HOLDINGS, INC. · CORCEPT THERAPEUTICS INC · SUPERNUS PHARMACEUTICALS, INC. · Collegium Pharmaceutical, Inc. · TG THERAPEUTICS, INC.

Stock screener

Watchlist